Spyre Therapeutics’ monoclonal antibody hit the key goal of a phase 2 study in ulcerative colitis (UC), which the company has touted as proof it can best Takeda’s Entyvio. The mid-stage trial ...
Tisotumab vedotin plus carboplatin and pembrolizumab improved survival outcomes in patients with recurrent/metastatic cervical cancer.
A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.
Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...
A 14-site phase 3 program enrolled adults with ≥6-month DED, OD4SQ symptom score ≥2, and Schirmer 1–10 mm, testing bilateral ...
Dateline is hitting the road for a first-of-its-kind event — and you're invited! On Sunday, September 28th, join us in Nashville, Tennessee, for Dateline LIVE, an exclusive event featuring the ...
A handy calendar for visits from the Jackalope, Blood Moon cult, and Krampus. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results